retatrutide nejm produces up to 30.3% weight loss in Phase 3 trial obesity #retatrutide #weight #glp1 #nejm
Description
Combining hormone replacement therapy (HRT) with semaglutide may improve weight reduction while also helping manage menopause symptomsa win-win for many patients
This "rebound hunger" can feel overwhelming and is a sign that your body is struggling to adjust
I encourage everyone on these medications to prioritize resistance training and protein intake
Combination therapy changes risk profile
An understanding of their effects on BP may help provide an explanation for the ability of GLP-1a to influence cardiovascular (CV) events in ongoing event-driven CV trials
